Catalyst Wire Dossier Catalyst Wire Dossier

Nilandron (nilutamide)

nilutamide
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nilandron (nilutamide), covering 2015-04-29 to 2015-04-29. Get the full timeline:

Most recent: Clinical Trial Update: Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate Cancer [Phase 2]

See pricing